首页 | 本学科首页   官方微博 | 高级检索  
     


Challenges and opportunities in RSV vaccine development: Meeting report from FDA/NIH workshop
Affiliation:1. Office of Vaccines Research and Review (OVRR), Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA;2. Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA;3. Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA;4. Department of Pediatrics and Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA;5. Division of Infectious Diseases, Department of Medicine, Rochester General Hospital, University of Rochester, Rochester, NY, USA;6. Department of Pediatrics, School of Medicine, Emory University and Children’s Healthcare of Atlanta, Atlanta, GA, USA;7. Division of Microbiology and Infectious Disease, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA;1. St Mary''s Hospital, Imperial College Healthcare NHS Trust, London, UK;2. Centre of International Child Health, Department of Paediatrics, Imperial College London, London, UK;3. Vaccines and Immunity Theme, MRC Unit, The Gambia, west Africa;1. Emory University Department of Pediatrics and Children׳s Healthcare of Atlanta, Atlanta, GA 30322, USA;2. Division of Viral Diseases, NCIRD, CDC, Atlanta, GA 30333, USA;3. University of Georgia Department of Infectious Diseases, Animal Health Research Center, Athens, GA 30602, USA;4. University of Georgia, Odum School of Ecology, Athens, GA 30602, USA;1. Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA;2. U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA;3. Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA;4. Department of Biochemistry, Geisel School of Medicine at Dartmouth, 7200 Vail, Hanover, NH 03755, USA;1. Initiative for Vaccine Research, World Health Organization, CH-1211 Geneva 27, Switzerland;2. U.S Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA;3. PATH, Seattle, WA 98109, USA;4. London School of Hygiene and Tropical Medicine, London WC1E7HT, UK;1. Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK;2. Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA;3. Foundation for Influenza Epidemiology, Fondation de France, Paris, France;4. Sanofi Pasteur, Lyon, France;5. OpenHealth, Paris, France;6. Netherlands Institute for Health Services Research (Nivel), Utrecht, Netherlands;7. Fogarty International Center, National Institutes of Health, Bethesda, MD, USA;8. Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, Netherlands
Abstract:
Keywords:RSV  Vaccination  Infants  Elderly  Maternal immunization  Vaccine-enhanced illness  Animal models  Subunit vaccine  Vaccine vector  Neutralization  Bronchitis  Wheezing  Human challenge  Clinical trials
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号